ES2650733T3 - Anticuerpo específico para el dominio C-terminal de la profilagrina y su uso - Google Patents

Anticuerpo específico para el dominio C-terminal de la profilagrina y su uso Download PDF

Info

Publication number
ES2650733T3
ES2650733T3 ES12848401.1T ES12848401T ES2650733T3 ES 2650733 T3 ES2650733 T3 ES 2650733T3 ES 12848401 T ES12848401 T ES 12848401T ES 2650733 T3 ES2650733 T3 ES 2650733T3
Authority
ES
Spain
Prior art keywords
domain
terminal
antibody specific
profilagrin
terminal domain
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
ES12848401.1T
Other languages
English (en)
Spanish (es)
Inventor
Toshihiko Hibino
Mami Yamamoto
Masaya TAKAGI
Junichi SAKABE
Yoshiki Tokura
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Shiseido Co Ltd
Original Assignee
Shiseido Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Shiseido Co Ltd filed Critical Shiseido Co Ltd
Application granted granted Critical
Publication of ES2650733T3 publication Critical patent/ES2650733T3/es
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6881—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids from skin
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/20—Dermatological disorders
    • G01N2800/202—Dermatitis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • General Physics & Mathematics (AREA)
  • Food Science & Technology (AREA)
  • Cell Biology (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Peptides Or Proteins (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
ES12848401.1T 2011-11-09 2012-11-08 Anticuerpo específico para el dominio C-terminal de la profilagrina y su uso Active ES2650733T3 (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2011245483A JP5771123B2 (ja) 2011-11-09 2011-11-09 プロフィラグリンｃ末端ドメイン特異的抗体及びその用途
JP2011245483 2011-11-09
PCT/JP2012/079015 WO2013069741A1 (ja) 2011-11-09 2012-11-08 プロフィラグリンc末端ドメイン特異的抗体及びその用途

Publications (1)

Publication Number Publication Date
ES2650733T3 true ES2650733T3 (es) 2018-01-22

Family

ID=48290111

Family Applications (1)

Application Number Title Priority Date Filing Date
ES12848401.1T Active ES2650733T3 (es) 2011-11-09 2012-11-08 Anticuerpo específico para el dominio C-terminal de la profilagrina y su uso

Country Status (7)

Country Link
US (2) US20140287431A1 (OSRAM)
EP (1) EP2778174B1 (OSRAM)
JP (1) JP5771123B2 (OSRAM)
KR (1) KR102025446B1 (OSRAM)
CN (1) CN104039827B (OSRAM)
ES (1) ES2650733T3 (OSRAM)
WO (1) WO2013069741A1 (OSRAM)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8956859B1 (en) 2010-08-13 2015-02-17 Aviex Technologies Llc Compositions and methods for determining successful immunization by one or more vaccines
WO2020076770A1 (en) * 2018-10-08 2020-04-16 Yale University Selective binding and aggregation of human keratin in the skin barrier using human filaggrin subdomains sd67 and sd150

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1992019649A1 (fr) * 1991-04-26 1992-11-12 Clonatec Antigenes reconnus par des anticorps de la polyarthrite rhumatoide, leur preparation et leurs applications
JP5039544B2 (ja) * 2004-06-18 2012-10-03 ジェネンテック， インコーポレイテッド 腫瘍の治療
GB0525492D0 (en) * 2005-12-15 2006-01-25 Univ Dundee Filaggrin
JP2007217325A (ja) * 2006-02-16 2007-08-30 Kose Corp プロフィラグリン及び／又はフィラグリン産生促進剤
JP5858788B2 (ja) * 2009-12-03 2016-02-10 株式会社 資生堂 ブレオマオシン水解酵素の活性を指標としたアトピー性皮膚炎による乾燥肌改善剤のスクリーニング方法

Also Published As

Publication number Publication date
CN104039827B (zh) 2016-12-14
US20190079080A1 (en) 2019-03-14
KR20140089366A (ko) 2014-07-14
EP2778174A1 (en) 2014-09-17
EP2778174A4 (en) 2015-06-24
EP2778174B1 (en) 2017-11-01
JP5771123B2 (ja) 2015-08-26
JP2013100249A (ja) 2013-05-23
HK1201856A1 (en) 2015-09-11
CN104039827A (zh) 2014-09-10
WO2013069741A1 (ja) 2013-05-16
KR102025446B1 (ko) 2019-09-25
US20140287431A1 (en) 2014-09-25

Similar Documents

Publication Publication Date Title
ES2486675T3 (es) Análogo de péptido de oxintomodulina
CL2019002264A1 (es) Anticuerpos anti-lag3 radiomarcados para la obtención de imágenes mediante inmuno-pet.
ES2570731T3 (es) Método de detección de cáncer
NZ595707A (en) Cancer antigen helper peptide
CL2017000200A1 (es) Célula huésped mejorada para producir proteinas
EA201490265A1 (ru) Ингибиторы тирозинкиназы брутона
CY1120055T1 (el) Αντικαρκινικη πρωτεϊνη συντηξης
EA201700111A1 (ru) Полипептидные конструкции и их применение
PE20130205A1 (es) Proteinas de union a il-1
PH12015502849B1 (en) Biomarkers for cognitive dysfunction diseases and method for detecting cognitive dysfunction disease using biomarkers
RU2019119609A (ru) Пептиды, способные реактивировать мутанты р53
MX2017008817A (es) Composiciones y metodos para la glicosilacion de proteinas.
BR112016016737A2 (pt) Peptídeos, dispositivos e métodos para detecção de anticorpos contra anaplasma
CY1118200T1 (el) Πολυπεπτιδια, πολυνουκλεοτιδια και συνθεσεις για χρηση στη θεραπεια λανθανουσας φυματιωσης
ECSP13012673A (es) Métodos y composiciones para inmunoterapia para enfermedad neural
Ghosh et al. Protein and mitochondria quality control mechanisms and cardiac aging
CL2014003112A1 (es) Célula bacteriana gram-negativa recombinante que comprende un gen spr mutante y un gen capaz de expresar o sobreexpresar proteínas capaces de facilitar el plegamiento de proteínas; y método para producir proteínas de interés.
MX358772B (es) Metodo para detectar cancer.
AR098126A1 (es) Anticuerpos anti-ly6e (locus e del complejo del antígeno 6 linfocítico), inmunoconjugados y métodos para usarlos
CL2012002900A1 (es) Secuencias de acido nucleico procedente de un virus causante del sindrome de miocardiopatia (cms) en peces; vector; celula huesped; vacuna de adn; proteina recombinante codificada; vacuna recombinante; inmunoensayo para la deteccion de dicho virus; kit de diagnostico; y uso de las mismas.
BR112015008036A2 (pt) população de peptídeos isolados, método para detectar em uma amostra um anticorpo, método para diagnosticar erliquiose monocítica e/ou granulocítica e kit
MX2015000686A (es) Metodo para detectar cancer.
EP2582849A4 (en) DETECTION OF NUCLEIC ACIDS AND PROTEINS
MX393714B (es) Anticuerpo para sesgar proporciones de sexos y metodos de uso del mismo.
CL2014000891A1 (es) Metodo de seleccion de pescado que comprende identificar en la muestra la presencia de variaciones de secuencia dentro de secuencias nucleotidicas o aminoacídicas de proteinas; anticuerpo que se une a dichas proteinas o secuencias; kit para identificar y/o determinar variantes de la calidad de la carne asociada a un gen/proteina; un arreglo de ácidos nucleicos.